课题基金 / 基金详情

项目摘要

项目成果

CHANGIZ GEULA的其他基金

相关文献

中文摘要
翻译
描述(由申请人提供):自使用组织化学方法证明斑块和缠结(阿尔茨海默病(AD)的病理标志)含有胆碱能酶乙酰胆碱酯酶(AChE)和丁基胆碱酯酶(BuChE)特异性活性以来,已有20多年。同样的方法表明,与正常神经元细胞体和轴突中发现的胆碱酯酶相比,这些ad相关的胆碱酯酶(AD-ChE)具有不同的特性,可能起源于胶质细胞,并可能具有不寻常的活性。生化研究表明,ChEs可能参与AD的病理,特别是因为它与斑块的形成及其主要成分淀粉样蛋白- (A)肽的产生有关。除了目前的ChE抑制剂治疗旨在改善AD的皮质胆碱能缺陷外,由于它们可能参与疾病过程,抑制斑块和缠结中的ChE也是可取的,并且可能更有益。然而,关于斑块和缠结中的ChEs的研究目前处于停滞状态,因为迄今为止唯一能够区分AD-ChEs和正常ChEs的方法是基于组织切片中组织化学活性的证明。目前还没有方法可以从斑块和缠结中特异性地分离ChEs。因此,没有关于AD-ChEs的生化特性以及它们是否对疾病病理做出特定贡献的直接信息。此外,针对AD-ChEs的ChE抑制剂的开发和临床前测试需要一种可以从组织中分离这些酶的方法。利用我们实验室最近的观察,一些乙酰胆碱在细胞外基质蛋白硫酸肝素蛋白聚糖(HSPG)的帮助下锚定在组织(如肌肉)上,并且HSPG也存在于斑块和缠结中,本应用中的实验将测试两种从斑块、缠结和神经胶质中分离乙酰胆碱的新方法。提出的研究的具体目的将检验以下假设:1。固定和新鲜冷冻组织切片中的斑块、缠结和胶质细胞中的胆碱酯酶,而不是神经元和轴突中的胆碱酯酶,会随着时间的推移被动释放到储存缓冲液中。2. 固定组织和新鲜冷冻组织中的斑块、缠结和胶质细胞中的胆碱酯酶在各种糖胺聚糖、肝素酶或蛋白酶处理后会释放出来,而不是神经元和轴突中的胆碱酯酶。3. 释放的胆碱酯酶将显示出与阿尔茨海默病大脑斑块、缠结、神经胶质和生物化学相同的分子和酶特征和抑制模式。成功分离和表征ad -ChE将允许对这些ChE物种可能的有害影响进行机制研究;将有助于设计和测试专门针对AD-ChEs的新抑制剂;并且,可能会导致AD- ches作为血液和脑脊液中AD的生物标志物的研究。阿尔茨海默病的斑块和缠结含有改变性质的胆碱能酶乙酰胆碱酯酶(AChE)和丁基胆碱酯酶(BuChE),已被认为参与疾病过程。然而,目前尚无从斑块和缠结中特异性分离AChE和BuChE的方法,本应用旨在填补这一空白。从斑块和缠结中成功分离和表征AChE和BuChE将有助于对这些酶可能产生的有害影响进行机制研究,将有助于设计和测试专门针对斑块和缠结中胆碱酯酶的新抑制剂,并可能导致斑块和缠结胆碱酯酶作为血液和脑脊液中AD的生物标志物的研究。
英文摘要
DESCRIPTION (provided by applicant): It has been over two decades since it was demonstrated using histochemical methods that plaques and tangles, the pathological hallmarks of Alzheimer's disease (AD), contain activity specific to cholinergic enzymes acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE). The same methodology demonstrated that these AD-related cholinesterases (AD-ChE) possess different properties when compared with cholinesterases found in normal neuronal cell bodies and axons, are likely to originate in glial cells and may possess unusual activities. Biochemical studies have indicated that ChEs may be involved in the pathology of AD, particularly as it relates to the genesis of plaques and production of their main constituent, the amyloid- (A) peptide. It has been suggested that in addition to current ChE inhibitor therapies aimed at ameliorating the cortical cholinergic deficit in AD, it would also be desirable and perhaps more beneficial to inhibit ChEs in plaques and tangles, due to their possible participation in the disease process. However, research regarding the ChEs in plaques and tangles is currently at a stand-still because the only methods to date that have allowed distinction between AD-ChEs and normal ChEs are based on histochemical demonstration of activity in tissue sections. There is no method available to specifically isolate ChEs from plaques and tangles. Therefore, there is no direct information on the biochemical properties of AD-ChEs and whether they make a specific contribution to disease pathology. Furthermore, the development and pre-clinical testing of ChE inhibitors that can specifically target AD-ChEs requires a method which can isolate these enzymes from tissue. Taking advantage of recent observations at our laboratory, the fact that some ChEs are anchored to tissues (such as muscle) with the aide of extracellular matrix proteins heparan sulphate proteoglycans (HSPG) and that HSPG are also present in plaques and tangles, the experiments in the present application will test two novel methods for isolation of ChEs from plaques, tangles and glia. The specific aims of the proposed research will test the following hypotheses: 1. Cholinesterases from plaques, tangles and glial cells but not neurons and axons in fixed and fresh frozen tissue sections will be passively released into storage buffer over time. 2. Cholinesterases from plaques, tangles and glial cells but not neurons and axons in fixed and fresh frozen tissue will be released upon treatment with various glycosaminoglycans, heparinases or proteases. 3. Released cholinesterases will display molecular and enzymatic characteristics and inhibition patterns identical to those demonstrated histochemically in plaques, tangles and glia and biochemically in AD brain. The successful isolation and characterization of AD-ChEs will allow mechanistic studies of the possible detrimental effects of these ChE species; will aide in design and testing of new inhibitors specifically targeting AD-ChEs; and, is likely to lead to investigation of AD-ChEs as biomarkers of AD in blood and CSF. Plaques and tangles of Alzheimer's disease contain the cholinergic enzymes acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) with altered properties that have been suggested to participate in the disease process. However, currently there are no methods available to isolate AChE and BuChE specifically from plaques and tangles, and the present application aims to fill in this gap. The successful isolation and characterization of AChE and BuChE from plaques and tangles will allow mechanistic studies of the possible detrimental effects of these enzyme species, will aide in design and testing of new inhibitors specifically targeting cholinesterases in plaques and tangles, and is likely to lead to investigation of plaque and tangle cholinesterases as biomarkers of AD in blood and cerebrospinal fluid.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.bbagen.2011.08.010
发表时间: 2011-12
期刊: BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
影响因子: 3
作者: [Walsh, Ryan, Rockwood, Kenneth, Martin, Earl, Darvesh, Sultan]
通讯作者: Darvesh, Sultan
DOI: 10.1097/nen.0b013e31823cc7a6
发表时间: 2012-01
期刊: Journal of neuropathology and experimental neurology
影响因子: 3.2
作者: [Darvesh S, Cash MK, Reid GA, Martin E, Mitnitski A, Geula C]
通讯作者: Geula C
Cognitive SuperAging: A model to explore resilience and resistance to aging and Alzheimers disease
  • 批准号:
    10901316
  • 项目类别:
  • 资助金额:
    $74.79万
  • 财政年份:
    2023
  • 负责人:
    CHANGIZ GEULA
  • 依托单位:
Study to Uncover Pathways to Exceptional Cognitive Resilience in Aging (SUPERAging)
Research Education Component
Biospecimen/Neuropathology Core